NCT00299780View on ClinicalTrials.gov

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

April 30, 2007

Conditions
LymphomaMultiple MyelomaAcute Myelogenous Leukemia
Interventions
DRUG

Stem cell mobilization

Trial Locations (3)

77030

MD Anderson Cancer Center, Houston

02115

Dana Farber Cancer Institute, Boston

02116

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00299780 - Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | Biotech Hunter | Biotech Hunter